Membrane reorganization during chilling: Implications for long-term stabilization of platelets

Cryobiology

Volumn 43, Issue 2, 2001, Pages 114-123

  Tablin, Fern ^a   Wolkers, Willem F ^a   Walker, Naomi J ^a   Oliver, Ann E ^a   Tsvetkova, Nelly M ^a   Gousset, Karine ^a   Crowe, Lois M ^a   Crowe, John H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TREHALOSE;

CONFERENCE PAPER; CRYOPRESERVATION; ENDOCYTOSIS; FREEZE DRYING; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MOLECULAR STABILITY; PHASE SEPARATION; PHASE TRANSITION; PRIORITY JOURNAL; STORAGE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0036192156     PISSN: 00112240     EISSN: None     Source Type: Journal    
DOI: 10.1006/cryo.2001.2355     Document Type: Conference Paper

References (36)

1. The basis for toxicity of certain cryoprotectants: An hypothesis
2. Trehalose: A cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage
3. Platelet activation may explain the storage lesion in platelet concentrations
4. Cryopreservation of human platelets with dimethyl-sulfoxide: Changes in biochemistry and cell function
5. Functions of lipid rafts in biological membranes
6. The cellular and molecular basis of the platelet storage lesions: A symposium summary
7. Anhydrobiosis
8. Are lipid phase transitions responsible for chilling damage in platelets?
9. The role of vitrification in anhydrobiosis
10. Membrane phase transitions are responsible for imbibitional damage in dry pollen
11. The trehalose myth revisited: Introduction to a symposium on stabilization of cells in the dry state
12. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36
13. Active Lyn protein tyrosine kinase is selectively enriched within membrane microdomains of resting platelets
14. Evidence for a physiological role for membrane rafts in human platelets
15. Selective partitioning of receptors and signaling molecules in raft membrane domains of human platelets
16. Factors affecting leakage of trapped solutes from phospholipid vesicles during thermotropic phase transitions
17. Lateral organization and domain formation in two-component lipid membranes
18. Trehalose lowers membrane phase transitions in dry yeast cells
19. Lateral heterogeneity in human platelet plasma membrane and lipids from the time-resolved fluorescence of trans-parinaric acid
20. Molecular order and fluidity of the plasma membrane of human platelets from time-resolved fluorescence depolarization
21. Effect on platelet properties of exposure to temperatures below 20°C for short periods of storage at 20 to 24°C
22. The internal calcium concentration of human platelets increases during chilling
23. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles
24. Partitioning of indocarbocyanine probes between coexisting gel and fluid phases in model membranes
25. Redistribution of alpha-granules and their contents in thrombin stimulated platelets
26. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
27. The membrane phase transition of intact human platelets - Correlation with cold-induced activation
28. Platelet intermediate filaments: Detection of a vimentin-like protein in human and bovine platelets
29. Physical properties of membrane fractions isolated from human platelets: Implications for chilling induced platelet activation
30. Lipid phase separation correlates with activation in platelets during chilling
31. A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at -80°C
32. An ultrastructural basis for shape changes induced in platelets by chilling
33. Microtubule reassembly in surface-activated platelets
34. Human platelets loaded with trehalose survive freeze-drying
35. Mechanism of shape change in chilled human platelets
36. Reversible alterations in platelet morphology produced by anticoagulants and cold